Ardent Health (NYSE:ARDT) Stock Rating Upgraded by Zacks Research

Ardent Health (NYSE:ARDTGet Free Report) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Monday, Zacks reports.

A number of other analysts have also recently issued reports on ARDT. Royal Bank Of Canada increased their price objective on Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Truist Financial lifted their target price on Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Wall Street Zen lowered Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Weiss Ratings cut Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. Finally, The Goldman Sachs Group reissued a “neutral” rating and issued a $13.00 price target on shares of Ardent Health in a report on Thursday, August 6th. Seven equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Ardent Health presently has an average rating of “Hold” and a consensus target price of $13.05.

Get Our Latest Stock Report on ARDT

Ardent Health Stock Down 1.6%

Ardent Health stock opened at $10.74 on Monday. The firm has a 50 day simple moving average of $10.74 and a 200 day simple moving average of $9.83. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. Ardent Health has a 1-year low of $7.71 and a 1-year high of $15.48. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of 19.53, a P/E/G ratio of 3.09 and a beta of 0.71.

Ardent Health (NYSE:ARDTGet Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.The company had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, analysts predict that Ardent Health will post 0.96 earnings per share for the current year.

Institutional Investors Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently made changes to their positions in ARDT. The Manufacturers Life Insurance Company grew its position in Ardent Health by 3.7% during the first quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company’s stock worth $255,000 after buying an additional 1,072 shares in the last quarter. Allworth Financial LP increased its stake in Ardent Health by 131.3% in the 2nd quarter. Allworth Financial LP now owns 2,863 shares of the company’s stock worth $28,000 after acquiring an additional 1,625 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Ardent Health by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after acquiring an additional 1,769 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Ardent Health by 8.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 27,530 shares of the company’s stock valued at $376,000 after acquiring an additional 2,110 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its holdings in shares of Ardent Health by 1,177.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after acquiring an additional 2,638 shares in the last quarter.

Ardent Health Company Profile

(Get Free Report)

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

Read More

Analyst Recommendations for Ardent Health (NYSE:ARDT)

Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.